UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

A medical worker holds a vial of AstraZeneca COVID-19 vaccine at a vaccination center, amid the coronavirus disease outbreak, in Ronquieres, Belgium Apr 6, 2021. REUTERS
The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome, or GBS, as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on Thursday.

Medicines and Healthcare products Regulatory Agency's decision comes after the European medicines agency added GBS as a possible side-effect last month.